1. Increased potency of recombinant VWF D′D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIII. (17th August 2021) Authors: Chia, Jenny; Pestel, Sabine; Glauser, Isabelle; Emmrich, Kerstin; Hardy, Matthew P.; Mischnik, Marcel; Raquet, Elmar; Tomasetig, Vesna; Claar, Philipp; Zalewski, Anton; Bass, Gregory T.; Turnbull, Victor; Chen, Chao‐Guang; Wilson, Michael J.; Panousis, Con; Weimer, Thomas; Andrews, Arna; Verhagen... Journal: Journal of thrombosis and haemostasis Issue: Volume 19:Number 11(2021) Page Start: 2710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Generation of a humanized FXII knock‐in mouse—A powerful model system to test novel anti‐thrombotic agents. (19th August 2021) Authors: Beck, Sarah; Stegner, David; Loroch, Stefan; Baig, Ayesha A.; Göb, Vanessa; Schumbrutzki, Cornelia; Eilers, Eva; Sickmann, Albert; May, Frauke; Nolte, Marc W.; Panousis, Con; Nieswandt, Bernhard Journal: Journal of thrombosis and haemostasis Issue: Volume 19:Number 11(2021) Page Start: 2835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. One-step zero-background IgG reformatting of phage-displayed antibody fragments enabling rapid and high-throughput lead identification. Issue 4 (16th November 2013) Authors: Chen, Chao-Guang; Fabri, Louis J.; Wilson, Michael J.; Panousis, Con Journal: Nucleic acids research Issue: Volume 42:Issue 4(2014) Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FXIIa inhibitor rHA‐Infestin‐4: Safe thromboprotection in experimental venous, arterial and foreign surface‐induced thrombosis. (27th March 2016) Authors: May, Frauke; Krupka, Jennifer; Fries, Marion; Thielmann, Ina; Pragst, Ingo; Weimer, Thomas; Panousis, Con; Nieswandt, Bernhard; Stoll, Guido; Dickneite, Gerhard; Schulte, Stefan; Nolte, Marc W. Journal: British journal of haematology Issue: Volume 173:Number 5(2016) Page Start: 769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab. Issue 3 (3rd December 2021) Authors: McKenzie, Andrew; Roberts, Anthony; Malandkar, Sourabh; Feuersenger, Henrike; Panousis, Con; Pawaskar, Dipti Journal: Clinical and translational science Issue: Volume 15:Issue 3(2022) Page Start: 626 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Factor XII blockade inhibits aortic dilatation in angiotensin II-infused apolipoprotein E-deficient mice. Issue 9 (4th May 2020) Authors: Moran, Corey S.; Seto, Sai-Wang; Biros, Erik; Krishna, Smriti M.; Morton, Susan K.; Kleinschnitz, Christoph; Panousis, Con; Golledge, Jonathan Journal: Clinical science Issue: Volume 134:Issue 9 (2020) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors. Issue 3 (2nd April 2016) Authors: Panousis, Con; Dhagat, Urmi; Edwards, Kirsten M.; Rayzman, Veronika; Hardy, Matthew P.; Braley, Hal; Gauvreau, Gail M.; Hercus, Timothy R.; Smith, Steven; Sehmi, Roma; McMillan, Laura; Dottore, Mara; McClure, Barbara J.; Fabri, Louis J.; Vairo, Gino; Lopez, Angel F; Parker, Michael W.; Nash, Andr... Journal: MAbs Issue: Volume 8:Issue 3(2016) Page Start: 436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure. Issue 1 (31st December 2023) Authors: Ow, Saw Yen; Kapp, Eugene A.; Tomasetig, Vesna; Zalewski, Anton; Simmonds, Jason; Panousis, Con; Wilson, Michael J.; Nash, Andrew D.; Pelzing, Matthias Journal: MAbs Issue: Volume 15:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure. Issue 1 (31st December 2023) Authors: Ow, Saw Yen; Kapp, Eugene A.; Tomasetig, Vesna; Zalewski, Anton; Simmonds, Jason; Panousis, Con; Wilson, Michael J.; Nash, Andrew D.; Pelzing, Matthias Journal: MAbs Issue: Volume 15:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗